Effect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis

dc.creatorAbboud, Cely Saad
dc.creatorRao, Gauri G.
dc.creatorSouza, Ercilia E.
dc.creatorZavascki, Alexandre P.
dc.creatorKiffer, Carlos [UNIFESP]
dc.date.accessioned2020-07-08T13:09:55Z
dc.date.accessioned2023-09-04T19:02:30Z
dc.date.available2020-07-08T13:09:55Z
dc.date.available2023-09-04T19:02:30Z
dc.date.created2020-07-08T13:09:55Z
dc.date.issued2018
dc.identifierBrazilian Journal Of Infectious Diseases. Rio De Janeiro, v. 22, n. 1, p. 51-54, 2018.
dc.identifier1413-8670
dc.identifierhttps://repositorio.unifesp.br/handle/11600/54301
dc.identifierS1413-86702018000100051.pdf
dc.identifierS1413-86702018000100051
dc.identifier10.1016/j.bjid.2017.10.006
dc.identifierWOS:000432647100009
dc.identifier.urihttps://repositorioslatinoamericanos.uchile.cl/handle/2250/8622036
dc.description.abstractA retrospective cohort study, were evaluated: polymyxin B plus aminoglycosides or polymyxin B plus other antibiotics. Any degree of acute kidney injury occurred in 26 (86.6%) patients. The median time to acute kidney injury was 6.0 (95% CI 3-14) days in the polymyxin-aminoglycoside containing regimen group, against 27.0 (95% CI 6-42) days in the polymyxin with other antimicrobial combinations group (p = 0.03). Polymyxin B with aminoglycosides group progressed faster to any degree of renal dysfunction. (C) 2017 Sociedade Brasileira de Infectologia. Published by Elsevier Editora Ltda. This is an open access article under the CC BY-NC-ND license.
dc.languageeng
dc.publisherElsevier Brazil
dc.relationBrazilian Journal Of Infectious Diseases
dc.rightsAcesso aberto
dc.subjectAKI
dc.subjectCRE
dc.subjectPolymyxins
dc.subjectAminoglicosides
dc.titleEffect of polymyxin B-containing regimens on renal function for the treatment of carbapenem-resistant Enterobacteriacea mediastinitis
dc.typeArtigo


Este ítem pertenece a la siguiente institución